{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:16:23Z","timestamp":1791486983468,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Department of Science and Technology, China Administration of Traditional Chinese Medicine","award":["GZY-KJS-SD-2023-055"],"award-info":[{"award-number":["GZY-KJS-SD-2023-055"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The relationship between adjunctive traditional Chinese medicine therapy and symptom resolution in viral influenza has not been thoroughly examined. This study aimed to evaluate whether the addition of Mahuang Fuzi Xixin (MFX) decoction to standard antiviral therapy improves clinical outcomes in patients with early-stage viral influenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a randomized controlled study involving 61 patients with viral influenza symptoms presenting within 48 hours of onset. Participants were assigned based on disease severity, age, and sex in a 1:1 ratio to either the MFXD plus antiviral drugs group (MFXD group, n = 31) or the antiviral drugs alone group (control group, n = 30). Fever duration and virological clearance were compared between groups during and after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After 5 days, the MFXD group exhibited a significantly shorter fever duration (27.4\u2009\u00b1\u200911.1 hours) compared to the control group (60.9\u2009\u00b1\u200921.6 hours;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). By day 3, 22 of 35 patients (62.9%) in the MFXD group had become afebrile, compared with 12 of 33 (36.4%) in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .028). By day 5, fever resolution was achieved in 30 of 31 evaluable patients (96.8%) in the MFXD group versus 19 of 30 (63.3%) in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .002). Additionally, at the end of treatment, 23 patients (74.2%) in the MFXD group tested negative for influenza viruses, adenovirus, or mycoplasma pneumoniae, compared with 13 patients (43.3%) in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .029).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The early combined use of MFXD and antiviral drugs accelerates symptom resolution and virological clearance. MFXD may be a beneficial adjunctive treatment for elderly patients with viral influenza.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045604","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:40Z","timestamp":1763571760000},"page":"e45604","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Mahuang Fuzi Xixin decoction combined with oseltamivir and ribavirin for aged patients with viral flu during the recent influenza pandemic in Mainland China: A randomized controlled trial"],"prefix":"10.1097","volume":"104","author":[{"given":"Mei","family":"Yu","sequence":"first","affiliation":[{"name":"Shandong Medical College, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Zhen","family":"Zu","sequence":"additional","affiliation":[{"name":"Yinan Hospital of Traditional Chinese Medicine, Linyi, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yang","family":"Guo","sequence":"additional","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9176-0364","authenticated-orcid":false,"given":"Lian-Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Medical College, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","article-title":"What\u2019s behind China\u2019s mysterious wave of childhood pneumonia?","year":"2023","journal-title":"Nature"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/pathogens11020237","article-title":"Inhibition of influenza virus replication by oseltamivir derivatives.","volume":"11","author":"Chan","year":"2022","journal-title":"Pathogens"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment of influenza-related lower respiratory tract complications and hospitalizations.","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch Intern Med"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/v16081300","article-title":"Whole-genome analysis of the Influenza A(H1N1)pdm09 viruses isolated from influenza-like illness outpatients in Myanmar and community-acquired oseltamivir-resistant strains present from 2015 to 2019.","volume":"16","author":"Chon","year":"2024","journal-title":"Viruses"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study.","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1002\/jmv.27870","article-title":"Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic.","volume":"94","author":"Zhang","year":"2022","journal-title":"J Med Virol"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/irv.12534","article-title":"Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the influenza resistance information study.","volume":"12","author":"Lina","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"e70042","DOI":"10.1111\/irv.70042","article-title":"Virological and clinical outcomes of influenza outpatients treated with baloxavir, oseltamivir, or laninamivir in the 2023\u20132024 season.","volume":"18","author":"Goto","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.celrep.2019.07.099","article-title":"Ribavirin induces polyamine depletion via nucleotide depletion to limit virus replication.","volume":"28","author":"Tate","year":"2019","journal-title":"Cell Rep"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem-cell transplant recipients.","volume":"29","author":"Howard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.coph.2010.04.013","article-title":"Pharmacotherapy of respiratory syncytial virus infection.","volume":"10","author":"Welliver","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"1206454","DOI":"10.3389\/fmicb.2023.1206454","article-title":"Mahuang Fuzi Xixin decoction ameliorates allergic rhinitis and repairs the airway epithelial barrier by modulating the lung microbiota dysbiosis.","volume":"14","author":"Wei","year":"2023","journal-title":"Front Microbiol"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"3812180","DOI":"10.1155\/2020\/3812180","article-title":"Identification of active compounds of Mahuang Fuzi Xixin decoction and their mechanisms of action by LC-MS\/MS and network pharmacology.","volume":"2020","author":"Liang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R14-20260520","first-page":"811","article-title":"Phytochemistry and pharmacology of genus Ephedra.","volume":"16","author":"Zhang","year":"2018","journal-title":"Chin J Nat Med"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1080\/14786419.2017.1416385","article-title":"Antiviral activity of aconite alkaloids from Aconitum carmichaelii Debx.","volume":"33","author":"Xu","year":"2019","journal-title":"Nat Prod Res"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jep.2013.11.049","article-title":"Yakammaoto inhibited human Coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.","volume":"151","author":"Yen","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpba.2016.11.027","article-title":"Comparative tissue distribution and excretion study of alkaloids from Herba Ephedrae-Radix Aconiti Lateralis extracts in rats.","volume":"134","author":"Ren","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"114642","DOI":"10.1016\/j.jep.2021.114642","article-title":"The genus Asarum: a review on phytochemistry, ethnopharmacology, toxicology and pharmacokinetics.","volume":"282","author":"Liu","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S2095-4964(17)60329-7","article-title":"Effects of homoeopathic ultrahigh dilutions of Aconitum napellus on Baker\u2019s yeast-induced fever in rabbits.","volume":"15","author":"Ahmad","year":"2017","journal-title":"J Integr Med"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4314\/tjpr.v14i3.26","article-title":"Phytochemical, toxicological and pharmacological studies of asiasari radix et rhizoma: a review.","volume":"14","author":"Ramalingam","year":"2015","journal-title":"Trop J Pharm Res"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jep.2016.07.017","article-title":"Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice.","volume":"192","author":"Rong","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"116070","DOI":"10.1016\/j.jep.2022.116070","article-title":"Mahuang Xixin Fuzi decoction protects the BALB\/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response.","volume":"304","author":"Liu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2022.09.009","article-title":"Ephedrae Herba polysaccharides inhibit the inflammation of ovalbumin induced asthma by regulating Th1\/Th2 and Th17\/Treg cell immune imbalance.","volume":"152","author":"Zhang","year":"2022","journal-title":"Mol Immunol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijbiomac.2011.06.017","article-title":"Antioxidant and immunological activities of water-soluble polysaccharides from Aconitum kusnezoffii Reichb.","volume":"49","author":"Gao","year":"2011","journal-title":"Int J Biol Macromol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fphar.2019.00961","article-title":"Screening of antiviral components of ma huang tang and investigation on the ephedra alkaloids efficacy on influenza virus type A.","volume":"10","author":"Wei","year":"2019","journal-title":"Front Pharmacol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3892\/etm.2021.9924","article-title":"Anti-inflammatory and anti-rheumatic activities in vitro of alkaloids separated from Aconitum soongoricum Stapf.","volume":"21","author":"Zhang","year":"2021","journal-title":"Exp Ther Med"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3892\/etm.2014.1941","article-title":"Protective effect of Asarum extract in rats with adjuvant arthritis.","volume":"8","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1142\/S0192415X18500349","article-title":"Asatone prevents acute lung injury by reducing expressions of NF-[Formula: see text]B, MAPK and inflammatory cytokines.","volume":"46","author":"Chang","year":"2018","journal-title":"Am J Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:02:31Z","timestamp":1779274951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":28,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045604","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2024-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}